News
American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
CAT Sims has opened up about turning to Mounjaro after quitting booze and drugs lead her turning to food and piling on three ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use ...
After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Hims did not provide financial terms of the deal, but a company spokesperson said these details will be shared with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results